Angiotensin-II, renal anemia and hyporesponsiveness to recombinant human erythropoietin.
Schiffl
H
H
Bergner
A
A
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000804:Angiotensin II / Q000008:administration & dosage*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011994:Recombinant Proteins; D012680:Sensitivity and Specificity
D000806:Angiotensin-Converting Enzyme Inhibitors; D011994:Recombinant Proteins; D004921:Erythropoietin; D000804:Angiotensin II